13.5.2 Photodamage
The 2007 British Association of Dermatologists guidelines suggest that ‘no therapy’ or ‘emollient only’ are reasonable options for mild actinic keratoses. Where treatment is warranted, the table below specifies the formulary treatment options.
MHRA safety update: Ingenol mebutate gel (Picato▼): suspension of the licence due to risk of skin malignancy
Actinic keratosis Grade 1 | Actinic keratosis Grade 2 | Actinic keratosis thick, hyperkeratotic lesions Grade 3 | Small superficial basal cell carcinomas |
Diclofenac 3% gel (Solaraze®) |
Fluorouracil 5% cream (Efudix®) |
Liquid Nitrogen/ curettage | Imiquimod 5% cream (Aldara®) |
|
Moderately thick hyperkeratotic actinic keratosis Fluorouracil 0.5%/ salicylic acid 10% solution (Actikerall®) |
|
|
|
For face, scalp, genital areas Imiquimod 5% cream (Aldara®) |
|
|
Excipients include benzyl alcohol, cetyl alcohol, stearyl alcohol, hydroxybenzoates (parabens), polysorbate 60
Pack |
---|
12 sachet |
For use in licensed indications only - Click on EMC link to see Summary of Product Characteristics
Pack |
---|
2 gram |
- First Line Drugs
- Second Line Drugs
- Specialist Initiated Drugs
- Specialist Only Drugs
- Mixed Status